{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:56:29Z","timestamp":1792169789877,"version":"4.4.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejoncologynursing.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Oncology Nursing"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejon.2026.103350","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:15:54Z","timestamp":1791846954000},"page":"103350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Chemotherapy and immunotherapy in the final months of life: a retrospective cohort study in cancer patients"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2157-5001","authenticated-orcid":false,"given":"N.","family":"Bartels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1421-6246","authenticated-orcid":false,"given":"L.E.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.E.","family":"Sampimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"van Holstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Rijneveld-Guijt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"v.d. Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5169-6306","authenticated-orcid":false,"given":"J.E.A.","family":"Portielje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejon.2026.103350_bib1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.soncn.2018.06.012","article-title":"Advance care planning and end-of-life decision making for patients with cancer","volume":"34","author":"Agarwal","year":"2018","journal-title":"Semin. Oncol. Nurs."},{"issue":"1","key":"10.1016\/j.ejon.2026.103350_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13010145","article-title":"Use of palliative chemotherapy and ICU admissions in gastric and esophageal cancer patients in the last phase of life: a nationwide observational study","volume":"13","author":"Besseling","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"e1","key":"10.1016\/j.ejon.2026.103350_bib3","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1136\/bmjspcare-2020-002302","article-title":"Inappropriate end-of-life cancer care in a generalist and specialist palliative care model: a nationwide retrospective population-based observational study","volume":"12","author":"Boddaert","year":"2022","journal-title":"BMJ Support. Palliat. Care"},{"issue":"3","key":"10.1016\/j.ejon.2026.103350_bib4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.soncn.2018.06.001","article-title":"Integration of palliative care and oncology nursing","volume":"34","author":"Chow","year":"2018","journal-title":"Semin. Oncol. Nurs."},{"issue":"6","key":"10.1016\/j.ejon.2026.103350_bib5","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1200\/JCO.2003.03.059","article-title":"Identifying potential indicators of the quality of end-of-life cancer care from administrative data","volume":"21","author":"Earle","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.ejon.2026.103350_bib6","doi-asserted-by":"crossref","first-page":"639","DOI":"10.7326\/0003-4819-138-8-200304150-00011","article-title":"Chemotherapy use among medicare beneficiaries at the end of life","volume":"138","author":"Emanuel","year":"2003","journal-title":"Ann. Intern. Med."},{"issue":"10","key":"10.1016\/j.ejon.2026.103350_bib7","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1007\/s11864-023-01115-x","article-title":"Systemic anticancer treatment near the end of life: a narrative literature review","volume":"24","author":"Geyer","year":"2023","journal-title":"Curr. Treat. Options Oncol."},{"issue":"3","key":"10.1016\/j.ejon.2026.103350_bib8","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/01.EDE.0000042804.12056.6C","article-title":"Quantifying biases in causal models: classical confounding vs collider-stratification bias","volume":"14","author":"Greenland","year":"2003","journal-title":"Epidemiology"},{"issue":"7","key":"10.1016\/j.ejon.2026.103350_bib9","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1634\/theoncologist.2008-0257","article-title":"Factors that affect the duration of the interval between the completion of palliative chemotherapy and death","volume":"14","author":"Hashimoto","year":"2009","journal-title":"Oncologist"},{"issue":"11","key":"10.1016\/j.ejon.2026.103350_bib10","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/cncr.28628","article-title":"Impact of timing and setting of palliative care referral on quality of end-of-life care in cancer patients","volume":"120","author":"Hui","year":"2014","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejon.2026.103350_bib11","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1001\/jamaoncol.2023.6025","article-title":"Immunotherapy initiation at the end of life in patients with metastatic cancer in the US","volume":"10","author":"Kerekes","year":"2024","journal-title":"JAMA Oncol."},{"issue":"6","key":"10.1016\/j.ejon.2026.103350_bib12","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jamaoncol.2015.2378","article-title":"Chemotherapy use, performance status, and quality of life at the end of life","volume":"1","author":"Prigerson","year":"2015","journal-title":"JAMA Oncol."},{"issue":"9","key":"10.1016\/j.ejon.2026.103350_bib13","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/S1470-2045(17)30582-X","article-title":"Definition and recommendations for advance care planning: an international consensus supported by the European association for palliative care","volume":"18","author":"Rietjens","year":"2017","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.ejon.2026.103350_bib14","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/annonc\/mdw654","article-title":"Use of chemotherapy near the end of life: what factors matter?","volume":"28","author":"Rochigneux","year":"2017","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.ejon.2026.103350_bib15","article-title":"Chemotherapy and healthcare utilisation near the end of life in patients with cancer","volume":"27","author":"Schulkes","year":"2018","journal-title":"Eur. J. Cancer Care"},{"issue":"4","key":"10.1016\/j.ejon.2026.103350_bib16","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmacoepidemiology","volume":"167","author":"Suissa","year":"2008","journal-title":"Am. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.ejon.2026.103350_bib17","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/0269216316663508","article-title":"Palliative homecare is associated with reduced high- and low-acuity emergency department visits at the end of life: a population-based cohort study of cancer decedents","volume":"31","author":"Sutradhar","year":"2017","journal-title":"Palliat. Med."},{"issue":"8","key":"10.1016\/j.ejon.2026.103350_bib18","first-page":"1589","article-title":"Emergency department visits for symptoms experienced by oncology patients: a systematic review","volume":"20","author":"Vandyk","year":"2012","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.ejon.2026.103350_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g1219","article-title":"Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study","volume":"348","author":"Wright","year":"2014","journal-title":"Bmj"},{"issue":"9","key":"10.1016\/j.ejon.2026.103350_bib20","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1177\/1049909118763338","article-title":"Palliative chemotherapy near the end of life in oncology patients","volume":"35","author":"Zhang","year":"2018","journal-title":"Am. J. Hops. Palliat. Care"}],"container-title":["European Journal of Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388926002553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388926002553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:40:58Z","timestamp":1792168858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1462388926002553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":20,"alternative-id":["S1462388926002553"],"URL":"https:\/\/doi.org\/10.1016\/j.ejon.2026.103350","relation":{},"ISSN":["1462-3889"],"issn-type":[{"value":"1462-3889","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemotherapy and immunotherapy in the final months of life: a retrospective cohort study in cancer patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejon.2026.103350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103350"}}